Advisory Solutions Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.84M Buy
5,911
+1,410
+31% +$1.66M 1.45% 13
2026
Q2
$5.4M Buy
+4,501
New +$4.6M 1.83% 10

Other funds holding LLY

Advisory Solutions Group's LLY Position: Q3 2026 in Review

Advisory Solutions Group increased its Eli Lilly (LLY) stake by 31% in Q3 2026, buying an estimated $1.66M and bringing the position to 5,911 shares worth $6.84M. The position accounts for 1.45% of the portfolio, ranked #13.

Advisory Solutions Group first reported a position in LLY in Q2 2026 and has held it in 2 quarters since. 4,106 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Advisory Solutions Group held 5,911 shares of Eli Lilly worth $6.84M as of Q3 2026.
  • Advisory Solutions Group bought 1,410 Eli Lilly shares in Q3 2026, an estimated $1.66M.
  • Eli Lilly made up 1.45% of Advisory Solutions Group's portfolio in Q3 2026, its #13 holding.
  • Advisory Solutions Group first reported a position in Eli Lilly in Q2 2026 and has held it in 2 quarters since.
  • 4,106 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Advisory Solutions Group's 13F filing for Q3 2026, filed 14 Oct 2026.